Cidara Therapeutics, Inc. CDTX 深 沪
已收盘 01-07 16:00:00 美东时间
221.38
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 221.38
- 总市值 56.14亿
- 52周最高 221.42
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 15.22
- 委 比 0.00%
- 总股本 2535.81万
- 历史最高 382.60
- 量 比 0
- 振 幅 0.00%
- 历史最低 8.00
- 每 手 1
- 风险率 66.42%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多不再迷惘的制药商：2025年并购额暴涨124%，巨头狂扫创新药资产
那些关于药品定价政策及可能侵蚀利润的关税措施的最坏担忧均未成真，行业焦虑情绪得到明显缓解。 智通财经APP获悉，下周，制药商们将赴旧金山出席摩根大通医疗健康年...
01-10 00:49
不再迷惘的制药商：2025年并购额暴涨124%，巨头狂扫创新药资产
下周，制药商们将赴旧金山出席摩根大通医疗健康年会，心态较2025年显著放松。回溯一年前，他们还对美国总统唐纳德·特朗普的政策走向感到困惑迷惘;如今，此前笼罩的诸...
01-09 21:50
Merck completes cash tender offer for Cidara Therapeutics
Merck (MRK) has finished its cash tender offer for all outstanding shares of Cidara Therapeutics (CDTX) at a price of $221.50 per Cidara share. The deal, announced in November, has a value of $9.2B. M...
01-07 20:28
Merck Completes Cash Tender Offer At Purchase Price Of $221.50 Per Share Of Common Stock Of Cidara Therapeutics
Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced the successful completion of the cash tender offer, through a subsidiary, for all the outstanding shares of common stock of Cidara
01-07 19:55
Pfizer's New mRNA Flu Vaccine Outperforms Traditional Shot Against Predominant Strains
Pfizer-funded study finds a next-gen mRNA flu shot works better against current strains — but causes more short-term side effects.
2025-11-21 23:48
Guggenheim Downgrades Cidara Therapeutics to Neutral
Guggenheim analyst Seamus Fernandez downgrades Cidara Therapeutics (NASDAQ:CDTX) from Buy to Neutral.
2025-11-18 22:06
Top 2 Health Care Stocks That May Fall Off A Cliff This Month
As of Nov. 17, 2025, two stocks in the health care sector could be flashing a r...
2025-11-17 21:15
创新药下一波主升浪在等一个信号
（来源：商图药讯） 01 两笔百亿级Big Buy收购 把License-in送进历史陈列柜 不到四周，欧美并购市场连放两颗高爆弹： 11月3日，Pfizer以...
2025-11-17 19:30
默沙东650亿豪赌“超级流感药”
近日，默沙东与Cidara Therapeutics共同宣布，双方已签署最终协议，根据该协议，默沙东将以约92亿美元的总额收购Cidara。这一消息发布后，位于...
2025-11-17 14:09
